Hanobi is an American-owned research peptide manufacturer headquartered in Las Vegas, Nevada, with manufacturing partner facilities in Southern California. The company specializes in producing highly purified peptides, proteins, and amino acid derivatives for scientific research and development. With over a decade of experience, Hanobi is recognized for precision, consistency, and regulatory integrity. Peptides are produced through a tightly controlled process spanning synthesis, purification, and quality assurance to ensure reproducibility and batch consistency. Hanobi employs advanced solid-phase and solution-phase synthesis, combining automated and manual technologies for strict process control. Each product is analytically verified using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm sequence accuracy, molecular identity, and purity exceeding 99%. Quality and compliance are central to Hanobi’s operations. The company adheres to all applicable federal and state regulations, including FDA guidelines for research-use-only materials. All products are labeled “For Research Use Only (RUO)” and are not intended for human use. Hanobi is not a compounding facility. Raw materials are sourced from independently vetted suppliers, supporting purity, consistency, and traceability. Rigorous quality control standards enable reliable outcomes across pharmaceutical development, biochemical research, and advanced laboratory applications. Led by CEO David Lindberg, Hanobi invests continuously in innovation, infrastructure, and compliance to support the evolving needs of the research community. At Hanobi, quality is engineered. We deliver precision, transparency, and reliability for researchers who demand confidence in their materials.
| Website | https://hanobi.com/ |
| Employees | 2 (0 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular Hanobi employee's phone or email?